E4/DRSP Ovarian Function Inhibition Study
NCT03091595
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class
Conditions
Prevention of Pregnancy
Interventions
DRUG:
15 mg E4/3 mg DRSP
DRUG:
20 mcg EE/3 mg DRSP
Sponsor
Estetra